Results of GROC-rev salvage regimen: Gemcitabine, rituximab, and oxaliplatin chemotherapy with revlimid for relapsed/refractory aggressive non-Hodgkin lymphoma (NHL).

Fernando Cabanillas,Idalia Liboy,Alexis. Cruz,Pedro Gil Solivan,Noridza Rivera,Wandaly I. Pardo,Mirelis Acosta

Results of GROC-rev salvage regimen: Gemcitabine, rituximab, and oxaliplatin chemotherapy with revlimid for relapsed/refractory aggressive non-Hodgkin lymphoma (NHL).

2017

Fernando Cabanillas
Idalia Liboy
Alexis. Cruz
Pedro Gil Solivan
Noridza Rivera
Wandaly I. Pardo
Mirelis Acosta

7556Background: Currently there is no optimal salvage regimen for relapsed/refractory NHL (R/R NHL). Prognosis of pts who fail to achieve CR to salvage therapy is dismal. We sought to improve the C...

Keywords:

Refractory
Aggressive Non-Hodgkin Lymphoma
Pathology
Oncology
Regimen
Rituximab
Oxaliplatin
Gemcitabine
Medicine
Chemotherapy
Internal medicine
salvage regimen
Salvage therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations